Top Markets
Coin of the day
Maxigen Biotech Inc. Maxigen Biotech Inc.

Maxigen Biotech Inc.

1783
Rang in aandelen #21087
Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development,... Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development, production, and global commercialization of advanced biomedical and skincare solutions. Its extensive biomedical portfolio includes various orthopedic products such as Formagraft, a bone graft substitute, and Formasetin, a bone void filler. For intra-articular applications in orthopedics, MBI markets injections under the names ArtiAid, ArtiAid Plus, and ArtiBest. The company's offerings also span both orthopedic and dental fields, featuring Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental graft. Specifically for dental use, MBI provides FormaAid, a collagen membrane, and the E-TECH DENTISTAR II sterilizer and disinfectant. Furthermore, HealiAid, a collagen wound dressing product, serves dental and general wound care purposes. MBI also manufactures ophthalmic viscoelastic devices, known as ViscAid, PreviscAid, and BiVisc, and produces Formaderm, a dermal filler injection utilized in plastic surgery. Beyond its medical devices, Maxigen Biotech Inc. offers a comprehensive line of skincare products. This array includes masks for the face, neck, body, and limbs, alongside make-up removers, cleansers, exfoliants, toners, essences, men's grooming items, sunscreens, and specialized body, hand, and foot care formulations. Maxigen Biotech Inc. was established in 1998 and operates from its main office in Taoyuan City, Taiwan.
Aandeelprijs
$1.28
Laatst gesynchroniseerd: 2026-08-21
Marktkapitalisatie
$115.23M
Verandering (1 dag)
-0.25%
Verandering (1 jaar)
-10.17%
Land
TW
Handel Maxigen Biotech Inc. (1783)

Categorie

Prijs 1783 met de marktkapitalisatie van B
Maxigen Biotech Inc. Maxigen Biotech Inc.
1783
$1.28
Marktkapitalisatie van Maxigen Biotech Inc.(1783)
Marktkapitalisatie: $115.23M
Vanaf August 2026 heeft Maxigen Biotech Inc. een marktkapitalisatie van $115.23M. Dit maakt Maxigen Biotech Inc. volgens onze gegevens het 21087th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Maxigen Biotech Inc. van 2012 tot 2026
1783 vergeleken met de top 5 populairste stocks
Prijs voor 1783 Aandeel B Marktkapitalisatie van B uitslagen
Maxigen Biotech Inc. Maxigen Biotech Inc.
$58,099.29 $115.23M
$5.211T +4,522,369.46%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$50,689.70 $115.23M
$4.547T +3,945,604.16%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$46,405.64 $115.23M
$4.162T +3,612,131.42%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$40,054.47 $115.23M
$3.593T +3,117,753.81%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$31,136.32 $115.23M
$2.793T +2,423,562.31%